What is Figur8?
Figur8 is a health-technology innovator specializing in the musculoskeletal (MSK) sector. Its core offering, the FDA-registered bMAP platform, utilizes sophisticated sensor arrays and AI-driven analytics to provide precise, objective biomechanical assessments. By moving away from subjective patient reporting, the company enables clinicians to generate actionable data that informs personalized treatment plans and optimizes recovery trajectories. The platform serves a tripartite market, addressing the specific needs of healthcare providers, insurance payers, and patients, ultimately aiming to reduce the economic burden of MSK conditions while improving long-term health outcomes.
How much funding has Figur8 raised?
Figur8 has raised a total of $25M across 1 funding round:
Series A
$25M
Series A (2023): $25M with participation from Phoenix Venture Partners, DigiTx Partners, and First Spark Ventures
Key Investors in Figur8
Phoenix Venture Partners
A venture capital firm specializing in transforming innovative technologies into market-ready products, with a focus on advanced materials and novel devices.
DigiTx Partners
A firm dedicated to early-stage digital health investments, focusing on personalized medicine, data analytics, and digital therapeutics.
First Spark Ventures
A Deep Tech fund that invests in breakthrough technologies across Advanced Compute, Digital Biology, and CyberPhysical Systems.
What's next for Figur8?
With this major strategic investment, Figur8 is poised to deepen its market penetration within the enterprise healthcare space. The company's roadmap likely involves expanding its clinical footprint, enhancing its data-driven risk evaluation tools for insurance payers, and refining its AI algorithms to support more complex diagnostic scenarios. As the firm scales, the focus will shift toward establishing bMAP as the industry standard for objective MSK assessment, potentially driving new efficiencies in claims management and clinical decision support. The integration of these technologies into existing electronic health record systems remains a key strategic priority for sustained growth.
See full Figur8 company page
